AbbVie Inc.
Ticker: 1551152
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 17.0K+13.3% | 15.0K-4.9% | 15.8K+2.3% | 15.4K+15.6% | 13.3K-7.7% | 14.5K-0.0% | 14.5K+17.5% | 12.3K |
| Total Income | 17.0K+13.3% | 15.0K-4.9% | 15.8K+2.3% | 15.4K+15.6% | 13.3K-7.7% | 14.5K-0.0% | 14.5K+17.5% | 12.3K |
| EXPENSES | ||||||||
| Expenditure | 10.6K-4.1% | 11.0K-20.6% | 13.9K+31.8% | 10.5K+9.6% | 9.6K-9.6% | 10.6K+1.6% | 10.5K+10.0% | 9.5K |
| Tax | 662.00+93.6% | 342.00-35.0% | 526.00-14.2% | 613.00+64.8% | 372.00-28.5% | 520.00-32.7% | 773.00+101.8% | 383.00 |
| PROFIT | ||||||||
| PBT | 4.3K+311.7% | 1.0K+45.5% | 714.00-54.1% | 1.6K-6.4% | 1.7K-20.3% | 2.1K-2.9% | 2.1K+22.3% | 1.8K |
| Net Profit | 3.6K+419.9% | 695.00+273.7% | 186.00-80.2% | 938.00-27.1% | 1.3K-17.6% | 1.6K+13.9% | 1.4K+0.1% | 1.4K |
| KEY METRICS | ||||||||
| OPM % | 37.86%+11.26pp | 26.60%+14.53pp | 12.07%-19.66pp | 31.73%+3.75pp | 27.98%+1.48pp | 26.49%-1.15pp | 27.64%+4.92pp | 22.73% |
| NPM % | 21.27%+16.63pp | 4.63%+3.45pp | 1.18%-4.90pp | 6.08%-3.56pp | 9.64%-1.16pp | 10.79%+1.32pp | 9.47%-1.65pp | 11.12% |
| EPS | 2.04+423.1% | 0.39+290.0% | 0.10-80.8% | 0.52-27.8% | 0.72-18.2% | 0.88+14.3% | 0.77+0.0% | 0.77 |
Corporate Events
Board MeetingABBV
20268May
Board Meeting
Results of AbbVie's 2026 Annual Meeting of Stockholders, inc…
SEC Filing ↗